Ambulatory Hematopoietic Stem Cell Transplant (HSCT) for Severe Primary Immunodeficiency (PID) in Children
William Tse(Lurie Children's Hospital), Morris Kletzel(Lurie Children's Hospital), Jennifer Schneiderman(Northwestern University), Sonali Chaudhury(Northwestern University), R. Duerst(Northwestern University), David A. Jacobsohn(Children's National), Jessica Guarino(Northwestern University)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
|Journal of Clinical Oncology|2021|255
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248